Linnaeus Therapeutics, Inc.
Last verified 2026-05-07. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $5.0Mattributed |
|---|---|
| Latest round | Funding round, $5.0M, 2026-02-17attributed |
| Founded | unknown |
| Headquarters | Haddonfield, NJ |
| Industry | biotech |
| Stage | unknown |
| Website | linnaeus.com |
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-02-17 | Funding round | $5.0M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $5.0M | attributed | sec-edgar named as publisher. No document URL on file. |
| Total raised $5.0M | attributed | sec-edgar named as publisher. No document URL on file. |
| Company existence | self-reported | linnaeus.com, read 2026-05-07 |
| Description | self-reported | linnaeus.com, read 2026-05-07 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $5.0M, 2026-02-17 → Funding round, $5.0M, 2026-02-17, sec-edgar, No document URL on file | Latest round | seed, $5.0M, 2026-02-17 → Funding round, $5.0M, 2026-02-17 | sec-edgar, No document URL on file |
Records begin 2026-09-24. All changes